Cholecystectomy Devices Market Size & Growth Forecast 2027–2036, By Segments (Device, Surgery Type, End-use, Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Cholecystectomy Devices Market size was estimated at USD 63.45 million in 2026 and is projected to grow at a 6.51% CAGR from 2027 to 2036, surpassing USD 119.22 million by 2036. The industry revenue for 2027 is assessed at USD 66.93 million.
Get more details on this report
Request Free Sample ReportCholecystectomy Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 38.74% market share in 2026, supported by high procedural volumes, widespread minimally invasive surgery adoption, advanced hospital infrastructure, and established reimbursement systems.
- Asia Pacific is projected to grow at a 7.8% CAGR, driven by expanding laparoscopic surgery access, investments in operating room infrastructure, and increasing adoption of minimally invasive procedures.
Segment Momentum
- Conventional cholecystectomy devices led with 85.5% share in 2026 due to deep integration into standard procedures, strong surgeon familiarity, and compatibility with established operating room workflows and procurement practices.
- Robotic-assisted cholecystectomy devices are the fastest-growing segment as hospitals modernize operating rooms and prioritize precision-driven minimally invasive surgery, improving procedural control and encouraging adoption of advanced surgical platforms.
Market Expansion Drivers
- Rising gallstone prevalence and aging population driving surgical intervention demand.
- Increasing adoption of laparoscopic and robotic minimally invasive surgical procedures.
- Expansion of outpatient minimally invasive surgeries improving procedural efficiency.
Leading Market Participants
- Top players in the cholecystectomy devices market include Medtronic plc (Ireland), Stryker Corporation (United States), Olympus Corporation (Japan), Intuitive Surgical, Inc. (United States), B. Braun SE (Germany), Sklar Surgical Instruments (United States), Surgical Holdings Limited (United Kingdom), Millennium Surgical Corp. (United States), Surtex Instruments Limited (United Kingdom), GerMedUSA Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 63.45 million
- 2027 Estimated Market Size: USD 66.93 million.
- Projected Market Size: USD 119.22 million by 2036
- Growth Forecast: 6.51% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Conventional Cholecystectomy Devices (Device) | Laparoscopic Cholecystectomy (Surgery Type) | Hospitals (End-use) | Cholecystitis (Indication)
- Emerging Opportunity Segment: Robotic-assisted Cholecystectomy Surgery Devices (Device) | Laparoscopic Cholecystectomy (Surgery Type) | Ambulatory Surgical Centers (End-use) | Choledocholithiasis (Indication)
Market Growth Drivers and Industry Trends
Rising gallstone prevalence and aging population driving surgical intervention demand
An increasing burden of gallstone-related conditions, combined with population aging, will drive the cholecystectomy devices market growth by expanding the number of patients requiring surgical management. Gallstones can cause recurrent pain, inflammation, infection, and other complications that may require removal of the gallbladder when symptoms become significant or conservative management is insufficient. Older populations may also experience a greater burden of chronic and age-associated health conditions, increasing the number of patients evaluated for surgical intervention. As hospitals and surgical centers manage a broader pool of patients with symptomatic gallbladder disease, demand rises for instruments and devices used across procedures, including systems supporting tissue dissection, visualization, grasping, clipping, sealing, and specimen removal.
Increasing adoption of laparoscopic and robotic minimally invasive surgical procedures
Greater use of laparoscopic and robotic techniques is strengthening the cholecystectomy devices market as surgeons increasingly favor minimally invasive approaches for appropriate patients. Laparoscopic procedures use specialized instruments and visualization systems that allow surgeons to perform gallbladder removal through small incisions rather than conventional open surgery. Robotic platforms can provide enhanced instrument control, visualization, and dexterity for selected procedures, supporting continued technological development in surgical devices. The shift toward minimally invasive techniques is also encouraging hospitals to invest in specialized instrumentation and compatible surgical technologies, while surgeons gain greater familiarity with advanced approaches through training and procedural experience.
Expansion of outpatient minimally invasive surgeries improving procedural efficiency
The growing shift toward outpatient and shorter-stay surgical care is creating additional demand for efficient minimally invasive equipment, supporting the cholecystectomy devices market. Laparoscopic gallbladder removal can often be incorporated into streamlined surgical pathways that emphasize shorter recovery periods and efficient use of operating-room resources. As healthcare providers seek to improve patient throughput while maintaining procedural quality, there is greater emphasis on reliable instruments that enable efficient dissection, tissue handling, vessel closure, and specimen extraction. The development of ambulatory surgical capabilities and improved perioperative protocols is also allowing selected patients to receive minimally invasive treatment without prolonged hospitalization, increasing the importance of compact and dependable surgical device systems.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising gallstone prevalence and aging population driving surgical intervention demand | 2.50% | High | North America, Europe, Asia Pacific | High | Near Term |
| Increasing adoption of laparoscopic and robotic minimally invasive surgical procedures | 2.00% | High | North America, Europe | High | Mid Term |
| Expansion of outpatient minimally invasive surgeries improving procedural efficiency | 1.60% | High | North America, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the cholecystectomy devices market with a 38.74% share in 2026, supported by advanced surgical infrastructure, widespread use of minimally invasive procedures, and established standards for laparoscopic care. Healthcare providers increasingly favor surgical technologies that can improve procedural efficiency, support precise tissue handling, and reduce patient recovery burden. The region's well-developed hospital networks and access to advanced operating-room technologies facilitate adoption of specialized instruments used in gallbladder procedures. In addition, the prevalence of gallbladder-related disorders and continued investment in surgical modernization are sustaining demand for reliable and technologically advanced devices.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, benefiting from expanding hospital capacity, improving access to minimally invasive surgery, and rising healthcare expenditure. Greater availability of laparoscopic equipment and increasing clinical adoption of less invasive surgical techniques are creating favorable conditions for cholecystectomy device utilization. Growing urban populations and changing dietary patterns are contributing to demand for treatment of gallbladder disorders, while healthcare infrastructure investments are improving access to surgical care. Training initiatives, technology transfer, and expanding domestic medical-device capabilities are further supporting adoption and enabling healthcare facilities across emerging markets to incorporate more advanced surgical solutions.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
Germany 🇩🇪
Precision Surgical SystemsGermany emphasizes high-quality cholecystectomy devices designed to support standardized minimally invasive surgical procedures. Hospitals across Germany continue investing in reliable visualization systems and advanced surgical instruments that enhance procedural accuracy and clinical efficiency.
France 🇫🇷
Hospital Modernization SupportFrance is expanding the use of advanced cholecystectomy devices as hospitals modernize minimally invasive surgical capabilities. French healthcare providers continue prioritizing reliable surgical platforms that improve procedural consistency while supporting efficient patient management.
Italy 🇮🇹
Laparoscopic Procedure ExpansionItaly maintains steady demand for cholecystectomy devices that support minimally invasive surgical practices across public and private healthcare facilities. Medical centers in Italy continue upgrading laparoscopic equipment to improve procedural performance and enhance surgical outcomes.
Japan 🇯🇵
Procedure Efficiency FocusJapan prioritizes cholecystectomy devices that improve surgical precision while supporting efficient hospital workflows. Medical institutions in Japan increasingly adopt compact, technologically advanced laparoscopic equipment to optimize patient outcomes and reduce procedural complexity.
South Korea 🇰🇷
Surgical Technology AdoptionSouth Korea continues strengthening its cholecystectomy devices market through rapid adoption of advanced laparoscopic platforms and digital surgical technologies. Healthcare providers in South Korea increasingly integrate modern visualization and energy devices into routine gallbladder surgery procedures.
United States 🇺🇸
Advanced Minimally Invasive CareThe U.S. cholecystectomy devices market continues advancing through widespread adoption of laparoscopic and robotic-assisted surgical techniques. Healthcare providers in the U.S. prioritize precision instruments that improve procedural efficiency, patient recovery, and operating room workflow.
Cholecystectomy Devices Market Share (%), by Device, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportDevice Segment Analysis: Conventional Cholecystectomy Devices (Largest Segment) vs Robotic-assisted Cholecystectomy Surgery Devices (Fastest-Growing Segment)
Conventional cholecystectomy devices held the largest share of the cholecystectomy devices market, accounting for 85.5% in 2026. Their established use across gallbladder removal procedures, broad availability, and familiarity among surgical teams support their continued dominance. Conventional devices also benefit from compatibility with widely adopted surgical techniques and established operating-room workflows, allowing healthcare facilities to maintain efficient procedural practices without requiring extensive changes to existing infrastructure. Continued demand for cholecystectomy procedures and the need for dependable surgical instruments further reinforce adoption.
Robotic-assisted cholecystectomy surgery devices are gaining momentum as healthcare providers increasingly seek technologies that can improve surgical precision and procedural control. Robotic platforms can support surgeons through enhanced visualization, controlled instrument movement, and greater dexterity during minimally invasive interventions. Growing interest in advanced surgical technologies, efforts to improve procedural consistency, and the broader shift toward technology-enabled minimally invasive care are creating favorable conditions for faster adoption of robotic-assisted devices.
Surgery Type Segment Analysis: Laparoscopic Cholecystectomy (Largest & Fastest-Growing Segment)
Laparoscopic cholecystectomy dominated the cholecystectomy devices market and accounted for 76.42% in 2026, while also representing the fastest-growing surgery type. Its minimally invasive nature, smaller surgical incisions, reduced tissue trauma, and generally faster recovery compared with open procedures have made it a preferred approach for gallbladder removal. The widespread integration of laparoscopic techniques into surgical practice, supported by established clinical expertise and compatible instrumentation, continues to encourage utilization. Increasing preference for less invasive procedures among patients and healthcare providers is further strengthening the segment's market position.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Device | Conventional Cholecystectomy Devices, Robotic-assisted Cholecystectomy Surgery Devices | Conventional Cholecystectomy Devices | Robotic-assisted Cholecystectomy Surgery Devices |
| Surgery Type | Laparoscopic Cholecystectomy, Open Cholecystectomy | Laparoscopic Cholecystectomy | Laparoscopic Cholecystectomy |
| End-use | Hospitals, Ambulatory Surgical Centers, Others | Hospitals | Ambulatory Surgical Centers |
| Indication | Cholelithiasis, Choledocholithiasis, Cholecystitis, Pancreatitis, Others | Cholecystitis | Choledocholithiasis |
Competitive Landscape and Market Positioning
Major players in the cholecystectomy devices market:
1. Medtronic plc (Ireland)
2. Stryker Corporation (United States)
3. Olympus Corporation (Japan)
4. Intuitive Surgical Inc. (United States)
5. B. Braun SE (Germany)
6. Sklar Surgical Instruments (United States)
7. Surgical Holdings Limited (United Kingdom)
8. Millennium Surgical Corp. (United States)
9. Surtex Instruments Limited (United Kingdom)
10. GerMedUSA Inc. (United States)
Advances in minimally invasive surgery are strengthening the cholecystectomy devices market, with research focused on enhanced visualization systems, precision surgical instruments, and improved laparoscopic technologies that support safer procedures and faster patient recovery.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Medtronic plc (Ireland) | |||||||
| Stryker Corporation (United States) | |||||||
| Olympus Corporation (Japan) | |||||||
| Intuitive Surgical Inc. (United States) | |||||||
| B. Braun SE (Germany) | |||||||
| Sklar Surgical Instruments (United States) | |||||||
| Surgical Holdings Limited (United Kingdom) | |||||||
| Millennium Surgical Corp. (United States) | |||||||
| Surtex Instruments Limited (United Kingdom) | |||||||
| GerMedUSA Inc. (United States). |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Cholecystectomy Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Procedure Stage | Access & Entry Devices, Dissection Devices, Hemostasis Devices, Tissue Retrieval Devices, Closure Devices |
| Reusability | Single-Use Devices, Reusable Devices, Limited-Use Devices |
| Procurement Model | Direct Hospital Procurement, Group Purchasing Organization Procurement, Distributor-Based Procurement, Procedure-Based Supply Agreements |
Cholecystectomy Devices Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Hospital Procurement and Capital Purchasing Assessment |
|
| Ambulatory Surgery Center Adoption Outlook |
|
| Procedure Pathway and Technology Utilization Analysis |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
How big is the cholecystectomy devices market?
How is the cholecystectomy devices industry expected to grow over the next 10 years?
How is the shift toward minimally invasive surgery influencing purchasing priorities in the cholecystectomy devices market?
Why is the expansion of outpatient surgery becoming a significant growth driver for the cholecystectomy devices market?
Why do conventional cholecystectomy devices continue to dominate the market?
What is driving the rapid adoption of robotic-assisted cholecystectomy devices?
Why is North America the leading region for cholecystectomy devices?
What is supporting rapid growth of the cholecystectomy devices market in Asia Pacific?
Who are the major participants shaping the cholecystectomy devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
